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Abstract 
Aims: To assess the correlation between cognitive functioning and three gait parameters (gait speed, cadence 
and stride length) in persons with Mild Cognitive Impairment (MCI) and cognitively healthy controls and 
investigate linear correlations between gait and GM volumes. 
Methods: Participants were recruited at IRCCS San Camillo Hospital, Venice, Italy (MCI=43; age-matched 
controls=43). Participants underwent comprehensive neuropsychological assessment. Gait speed, cadence, 
and stride length, were assessed with the BTS FREEMG 300 device. Three-dimensional (3D) T1-weighted 
MR images were acquired using a 1.5 T Philips Achieva MRI system with a Turbo Field Echo sequence. 
Results: In MCI there was a positive correlation between gait speed and memory tests (p<0.05). In controls 
all three gait parameters correlated with executive functioning (p<0.01). Temporal and limbic areas (i.e. 
superior temporal gyrus, thalamus and parahippocampal gyrus) were associated with gait parameters in MCI 
whereas in controls the associations were with frontal areas (i.e. middle, inferior and superior frontal gyrus) 
and in the cerebellum (anterior and posterior lobe). 
Conclusions: Our results highlight a distinct pattern of association between GM volume and gait parameters 
in MCI patients and controls (temporal areas in MCI and frontal areas in healthy elderly), suggesting a 
relationship between dementia-related pathology and gait dysfunction.
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1. Introduction 
Mild cognitive impairment (MCI) is a syndrome characterized by significant cognitive deficits in persons 
without dementia1,21-2, and is associated with an increased rate of progression to dementia disorders such as 
Alzheimer’s disease (AD). However, MCI is a heterogeneous syndrome - a large percentage of patients 
progress to a full dementia state within five years, but a substantial proportion of persons remain stable or 
improve in cognitive functioning3. This raises the importance of identifying factors that predict cognitive 
decline in these patients. Several factors have been shown to increase progression to dementia in MCI 
patients, including psychiatric factors4, vascular factors5 , instrumental functioning deficits6, carotid 
atherosclerosis7, CSF and neuroimaging biomarkers8. Recently, research has focused on motor functioning, 
including gait control, as a potential clinical marker in persons in the prodromal phase of dementia.  
Gait control is a complex process involving various parameters, including walking speed, stride length, and 
cadence. A review suggested that several gait parameters should be examined in order to identify persons at 
risk of cognitive decline9, including gait variability and gait speed. In cognitively healthy persons, gait 
control is bilateral, and involves the hippocampus, prefrontal cortex, and parietal lobe10. Executive 
functioning is associated with balance control11 and gait control, particularly in persons with MCI and 
AD10,11. Other cognitive domains such as processing speed and memory are also associated with gait speed 
and other gait parameters in healthy persons and those with cognitive impairment12,13.  
Gait performance is often impaired in persons with AD, and gait-related problems such as falls are more 
common in dementia patients than in cognitively healthy older persons14,15. Gait and balance are associated 
with cognitive decline16,17 and progression to AD in patients with MCI16,17. Further, research suggests that 
specific MCI subtypes have different motor signatures18, with amnestic-MCI patients exhibiting slower gait 
performance during dual tasking10,19. A systematic review showed that slow walking speed combined with 
subjective cognitive impairment, a syndrome termed “motoric cognitive risk syndrome”, is associated with 
more than a twofold risk of incidence dementia20.  
The above evidence suggests that gait is often impaired in MCI, is associated with an increased risk of 
dementia, and is associated with cognitive functioning in specific domains. This raises the question of 
whether there are specific brain structures that are related to gait performance in MCI patients, which may 
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indicate an ongoing neurodegenerative process. One study investigated the association between hippocampal 
volumes and gait performance in MCI patients and cognitively healthy controls21. Although they identified a 
positive association between greater hippocampal volumes and poorer stride performance in cognitively 
healthy persons, they found no association for MCI patients in any gait parameters.  In contrast, another 
study demonstrated that poorer gait performance was associated with lower total white and grey matter (GM) 
and lower hippocampal volume in non-amnestic MCI patients21. Interestingly, the pattern of brain volume 
reduction was different for MCI patients compared to cognitively healthy controls. 
As the difference in GM volume involved in gait in MCI and cognitively unimpaired persons is still unclear, 
we aimed to investigate these parameters in a clinical sample of MCI patients compared to age-matched 
healthy controls in a motor-neurorehabilitation hospital in Venice, Italy. The specific objectives of the 
current study were to: 1) assess the correlation between domain-specific cognitive functioning and three gait 
parameters (gait speed, cadence and stride length) in persons with MCI and cognitively healthy controls; 2) 
identify differences in the correlation between cognitive functioning and the three gait parameters in persons 
with MCI compared to cognitively healthy controls and; 3) investigate linear correlations between GM 
volumes and the three gait parameters in MCI and healthy controls, and compare whether the associated 
structures differ between the two groups. 
2. Material and methods 
2.1 Participants.  
Forty-three MCI patients (mean age 74.7, SD 6.9; mean education 10.3, SD 4.2; females n=26, 60.5%) 
diagnosed according to Petersen et al’s criteria1,2 and 43 age-matched healthy controls (mean age 72.2, SD 
6.1; mean education 11.9, SD 4.1; females n=25, 58.1%) took part in the VPH-DARE@IT project, an FP7 
Project supported by the European Union. All participants were recruited at IRCCS San Camillo Hospital in 
Venice, Italy.  Only those able to walk independently without a gait aid (e.g. cane or walking stick) were 
included in the study. All participants underwent a complete neuropsychological assessment as well as an 
experimental gait protocol. The patient and control group did not differ in terms of demographics, however 
significant differences were found in gait speed, stride length and cadence (see Results). 
2.2 Ethics.  
 5 
The study was approved by the joint ethics committee of the Health Authority Venice 12 and the IRCCS San 
Camillo (Protocol number 2014.08).  All participants gave written informed consent prior to participation in 
the study. 
2.3 Neuropsychological assessment.  
Cognitive functioning was evaluated with a comprehensive neuropsychological assessment. The following 
standardized tests were used to evaluate several cognitive functions: the Mini-Mental State Examination 
(MMSE)22 to assess global cognition; Digit Span Forward and Backwards23, Prose Memory Test and the 
Paired Associates Test24,25 as measures of episodic memory, verbal short-term memory and working 
memory; Corsi Test23, Corsi Supra Span26, Rey-Osterrieth complex figure27 to measure visuospatial memory 
and visuoconstructive skills. Phonologic and semantic fluency were tested with the Letter Fluency Test24 and 
the Category Fluency Test24. The Digit Cancellation Test26 was used as a measure of visual search and speed 
of processing; a component of executive functioning was assessed with the short version of the Stroop Test27. 
The Token Test26 was chosen as a measure of comprehension and receptive language; the Similarities Test 
from the Wechsler Adult Intelligence Scale-Revised battery28 and the Raven Progressive Matrices29 were 
chosen as verbal and non-verbal measures of abstract reasoning respectively. Raw scores on tests were 
corrected for age and level of education for clinical purposes, using various sources of normative data except 
for the Digit Span Backwards for which no normative data exist for the relevant population.  
 
2.4 Gait assessment  
Participants were asked to walk a fixed distance (10 m) along a delimited indoor walkway, at their usual self-
selected walking speed in a quiet room. Spatial-temporal gait parameters, including gait speed, cadence 
(number of steps per minute) and stride length (distance walked from the heel-down time to the next heel-
down time of the same foot), were recorded using a specific tool – BTS FREEMG 300 – that provides 
integration of kinematics, dynamics, and surface electromyography all in one device. Ten meters of space 
was calibrated for collection of gait data in the system.  
Footswitches were used to define the contact points of deambulation. The BTS FREEEMG permits up to 8 
basographic zones to be measured, usually subdivided into 4 zones per side (right and left). The footswitches 
consist of a resistive membrane, 18 mm in diameter and with thickness of less than 0.5 mm, expressly 
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designed for applications in the analysis of movement. Acceleration and deceleration effects were later 
corrected during the phase of statistical analysis. 
 
2.5 MRI protocol and image processing.  
Three-dimensional (3D) T1-weighted MR images were acquired using a 1.5 T Philips Achieva MRI system 
with a Turbo Field Echo sequence. Voxel dimensions were 1.1 x 1.1 x 0.6 mm (gap 0.6 mm) and the field of 
view was 250 mm with a matrix size of 256 x 256 x 124. A number of pre-processing steps were followed, 
using SPM12 (Welcome Centre for Human Neuroimaging, UCL, London, UK)30, to obtain the GM and 
white matter (WM) segments from the 3D T1-weighted structural scan. This procedure included tissue-class 
segmentation and spatial smoothing, carried out with an 8mm Full-Width at Half Maximum Gaussian kernel. 
Smoothing was applied to reduce between participant variability and improve the normality of the 
distribution of the imaging data, both of which are important for statistical analysis. Global native –space 
volumes of GM, WM, and cerebrospinal fluid were extracted from all scans to compute total intracranial 
volume (TIV).  
2.6 Statistical analysis 
All statistical analyses were performed with IBM SPSS Statistics 20 software. The Shapiro-Wilk test was 
used to explore the normality of data distribution; non-parametric statistics were then used for further 
analyses. Specifically, differences between groups in all gait parameters (e.g. gait speed, cadence, stride 
length) were investigated using the Mann-Whitney test. T-tests were used to test differences in cognitive test 
between healthy controls and MCI. Spearman rho correlations were computed to test the association between 
cognitive tests and gait parameters. A Bonforoni correction was applied to account for multiple cognitive 
tests (n=20), with significance set at <0.0025. 
For the analysis of MRI, first, the reduction of GM volumes in the MCI group compared with the healthy 
control group was explored. Second, smoothed GM segments were entered into a voxel-based multiple 
regression analysis to investigate linear correlations between GM volumes and each gait parameter (gait 
speed, cadence and stride length) separately for each group (MCI and healthy controls). Age, years of 
education and total intracranial volume values were included as covariates in all multiple regression models. 
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Threshold was set at p < .05 for all MRI analyses. Significant MNI-space peak coordinates were converted 
into Talairach space using a non-linear transform31 and interpreted using the Daemon client32. 
3. Results 
The MCI and healthy control group did not differ significantly in demographic characteristics. There were 
differences in all gait parameters (i.e. gait speed, cadence, and stride length) between the two groups (Table 
1). As expected, MCI patients had poorer performance in comparison to healthy controls in all cognitive 
domains (Table 1).Spearman’s correlation analysis showed a significant relationship between gait parameters 
and some cognitive domains in controls (Table 2). There was a positive correlation between one gait 
parameter (i.e. gait speed) and the Stroop test, a test that measures executive functioning ( =-0.595, p < 
.000).  Stride length correlated with Digit Cancellation ( = .477, p < .001), Similarities ( = -.499, p < .001), 
Stroop error ( = -.589, p < .000), and Digit Span Backward ( = .477, p < .001).   
When the MCI group was compared with the healthy controls, differences in GM volumes were detected 
(Table 3). 
In the MRI analyses, a significant positive association in the healthy control group was found between 
average gait speed, cadence, stride length and GM volumes in frontal areas (i.e. middle, inferior and superior 
frontal gyrus) and in the cerebellum (anterior and posterior lobe) after adjustment for age, years of education 
and total intracranial volume values  
In the MCI group, average gait speed and stride length showed significant associations with GM volumes in 
the temporal and limbic areas (i.e. superior temporal gyrus, thalamus and parahippocampal gyrus).  The 
cadence parameter showed no significant association with GM volumes. Table 4 and Figure 1 show a 




The main findings of our study are that there are distinct patterns of association between GM volume and 
gait parameters in healthy elderly and MCI patients. Temporal and limbic areas (i.e. superior temporal gyrus, 
thalamus and parahippocampal gyrus) are associated with gait parameters in MCI whereas in healthy elderly 
the associations are with frontal areas (i.e. middle, inferior and superior frontal gyrus) and in the cerebellum 
(anterior and posterior lobe).  
This study shows that MCI patients present a specific association between gait parameters and grey matter 
loss in mediotemporal structures, highlighting a relationship between dementia-related pathology and gait 
dysfunction. These findings are in line with those of other studies; poorer gait performance was associated 
with lower total white and grey matter and lower hippocampal volume in non-amnestic MCI patients33  and 
these patterns were different for cognitively healthy persons where an association was only observed for the 
lower right hippocampal volume. It has also been reported that different patterns of brain volume 
reduction are associated with increased Timed Up and Go tests in MCI and cognitively healthy 
persons21. Another study reported an association between greater hippocampal volume and poorer gait 
performance in persons with subjective cognitive impairment34. 
It is interesting to note that gait in MCI is not associated with automatic motor areas such as the cerebellum, 
as was seen in the cognitively healthy controls, but instead was associated with the brain structures related to 
memory, including the temporal and limbic structures. A systematic review highlights that motoric cognitive 
risk syndrome is associated with low grey matter volume in the premotor and the prefrontal cortex20. 
These findings raise the question of whether gait changes from being an automatic function to being planned 
activity. A previous fMRI study demonstrated that activation patterns change with aging, as older persons 
have increased left hippocampal activation than younger persons during gait control, and a review concluded 
that poor mobility outcomes are associated with reduced grey and white matter volume35.  
Our study included age-matched controls with a mean age of 72.2 years, allowing us to differentiate between 
normal and pathological aging. In cognitively healthy older persons gait was associated with attention and 
executive functioning, and a recent meta-analysis concluded that interventions that combine physical and 
cognitive exercise with training of attention and executive functioning improve gait performance36. This 
highlights the importance of assessing gait control in all older individuals, not just those with MCI, as there 
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is a potential positive effect of interventions, which may in turn help the reduction of risk of falls and related 
negative outcomes. 
The strengths of our study include the comprehensive neuropsychological assessment, extensive gait 
analysis, and thorough MRI analysis.  We used a detailed diagnostic procedure for diagnosing MCI and 
included a matched control group. The fact that we included all types of MCI, not just amnestic-MCI can be 
viewed both as a strength and limitation.  On one hand, it is good to include all types of MCI patients, but on 
the other hand, it may be clinically interesting to focus on amnestic forms of MCI that are more often 
associated with the preclinical stages of AD. Another limitation is that our sample was quite small, but 
considering the extensive MRI and gait analysis, and the fact that we were able to identify significant 
associations, it is unlikely that this is a major problem. Unfortunately, we only assessed three measures of 
gait, yet it is a complex process that can include others measurements such as stance time, swing time, and 
double support, which have shown to be affected in persons with cognitive impairment18,37,38.   Further, we 
did not examine dual task gait, which may reveal interesting differences as dual-task gait performance 
significantly declines across the cognitive spectrum39. 
Our findings have important clinical relevance. Measures of gait might be useful proxies of cognitive decline 
in the early stage of AD-related neurodegeneration. Recent research suggest that cerebral Aβ deposition is 
associated with reduced gait speed in older adults with cognitive impairment40. Specific gait measures may 
be useful for predicting which patients will have a faster cognitive decline, and might be used as a marker of 
potential GM reduction in specific brain structures. As gait disturbances are symptoms that can be visually 
identified, and are relatively inexpensive to assess, it may be useful to screen for gait problems to identify 
persons in need of comprehensive neuropsychological testing. Importantly, clinical trials suggest that dual 
task performance can be improved with training in dementia patients41, and interventions that combine 
strength and balance training can improve gait performance in persons with both dementia and MCI42. Gait 
parameters are useful predictors of falls, which can cause fall-related injuries that affect quality of life and 
increased healthcare costs, for example, persons with both MCI and slow gait have a twofold risk of 
falling43. Therefore, gait analysis may be an important measure to include in the standard assessment of 
geriatric patients and those at risk for cognitive impairment. 
Future studies should focus on assessing dual task gait, which can provide additional valuable clinical 
information and it may have the potential to enhance diagnostic capabilities in MCI36. It is also relevant to 
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examine differences in MCI subtypes. For example, one study demonstrated that poorer gait performance 
was associated with lower total white and grey matter and lower hippocampal volume in non-amnestic MCI 
patients, but this association was not seen for amnestic-MCI patients33. Further, GM volume covariance 
associated with gait speed differs according to MCI subtype; it involves the frontal cortex in amnestic-MCI 
patients and subcortico-frontal regions in non-amnestic-MCI44. Also of interest would be to include imagined 
walking test assessment, such as a previous study33, which found that left premotor cortex volumes were 
associated with poorer imagined gait performance in non-amnestic MCI patients.  
In conclusion, our results highlight a distinct pattern of association between GM volume and gait parameters 
in healthy elderly and MCI patients (temporal areas in MCI and frontal areas in healthy elderly) and indicate 
that detection of gait abnormalities in a geriatric population has diagnostic valence and might flag 
individuals at greater risk of cognitive decline. 
 
Figure Legend 
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Figure 1. Association between GM volumes and gait parameters in MCI and healthy controls 
 
